Related Experiment Video
Updated: Feb 10, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MiRNA-93 functions as an oncogene in glioma by directly targeting RBL2
1School of Clinical Medicine, Tsinghua University, China. neurospinewgh@163.com.
Objective:
Glioma is a tumor of the brain. Although the clinical regimens and surgical techniques for glioma have improved, therapies of advanced glioma remain challenging, carrying dismal overall survival and therapeutic success rates. Evidence has shown that miRNAs played important roles in glioma development. The current study aimed at investigating the function of a novel cancerogenic miRNA, miR-93, in glioma progression by investigating the expression and mechanism of it.
Patients And Methods:
qRT-PCR was conducted to assess the miR-93 expression and the mRNA expression of target gene in glioma tissues and cells. The invasion and migration abilities of the glioma cells were determined by transwell assays. Luciferase reporter assay was performed to confirm the target of miR-93.
Results:
The results indicated that miR-93 expression in glioma tissues and cells was increased significantly than that in normal brain tissues and cells. Furthermore, miR-93 promoted glioma cell migration and invasion. RBL2 was recognized as a direct target of miR-93 in glioma cells, and overexpression of RBL2 could reverse the stimulative effect of miR-93 in glioma cell.
Conclusions:
The above findings suggested that miR-93 together with RBL2 could be diagnostic targets and novel prognostic markers for glioma.
Insights
MicroRNA-93 (miR-93) promotes glioma cell invasion and migration. Targeting miR-93 and its downstream target RBL2 may offer new diagnostic and prognostic strategies for glioma patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Glioma therapies face challenges, particularly in advanced stages.
- MicroRNAs (miRNAs) are implicated in glioma development.
- miR-93 is a novel, potentially cancer-promoting miRNA in glioma.
Purpose of the Study:
- Investigate the function of miR-93 in glioma progression.
- Determine the expression and mechanism of miR-93 in glioma.
Main Methods:
- Quantitative reverse transcription PCR (qRT-PCR) for gene expression analysis.
- Transwell assays to assess cell invasion and migration.
- Luciferase reporter assay to confirm miRNA targets.
Main Results:
- miR-93 expression is significantly elevated in glioma tissues and cells.
- miR-93 enhances glioma cell migration and invasion.
- RBL2 is a direct target of miR-93; its overexpression reverses miR-93's effects.
Conclusions:
- miR-93 promotes glioma progression by targeting RBL2.
- miR-93 and RBL2 show potential as diagnostic and prognostic markers for glioma.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Functional Groups
Functional Groups
Targeted Cancer Therapies
There are several types of targeted therapies against...
Functionalism
James envisioned psychology's...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

